113 related articles for article (PubMed ID: 6293991)
21. Neuromuscular defect after suppression of ion conductance.
Takamori M; Ide Y; Kasai M
Neurology; 1979 Jun; 29(6):772-9. PubMed ID: 221854
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of alpha-bungarotoxin binding to acetylcholine receptors by antisera from animals with experimental autoimmune myasthenia gravis.
Claudio T; Raftery MA
J Supramol Struct; 1980; 14(3):267-79. PubMed ID: 6971372
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of acetylcholine receptors in denervated muscle: interactions of receptors with immunoglobulin from patients with myasthenia gravis.
Mittag TW; Tormay A; Massa T
Mol Pharmacol; 1978 Jan; 14(1):60-8. PubMed ID: 625290
[No Abstract] [Full Text] [Related]
24. Rapsyn antibodies in myasthenia gravis.
Agius MA; Zhu S; Kirvan CA; Schafer AL; Lin MY; Fairclough RH; Oger JJ; Aziz T; Aarli JA
Ann N Y Acad Sci; 1998 May; 841():516-21. PubMed ID: 9668284
[No Abstract] [Full Text] [Related]
25. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
Schönbeck S; Chrestel S; Hohlfeld R
Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
[No Abstract] [Full Text] [Related]
26. Nerve stimulation test in murine experimental autoimmune myasthenia gravis.
Pachner AR; Kantor FS
Ann Neurol; 1982 Jan; 11(1):48-52. PubMed ID: 6277236
[TBL] [Abstract][Full Text] [Related]
27. [alpha-Bungarotoxin and acetylcholine receptor (author's transl)].
Takamori M; Ishii N; Tsujihata M; Mori M; Kasai M
No To Shinkei; 1977 Jun; 29(6):597-607. PubMed ID: 334200
[No Abstract] [Full Text] [Related]
28. [Animal models of myasthenia gravis].
Shigemoto K; Takashima R; Motohashi N; Mori S
Nihon Rinsho; 2015 Sep; 73 Suppl 7():97-104. PubMed ID: 26480686
[No Abstract] [Full Text] [Related]
29. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
30. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
Heilbronn E
Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
[No Abstract] [Full Text] [Related]
31. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
32. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
[TBL] [Abstract][Full Text] [Related]
33. [Myasthenia gravis--clinical and laboratory analysis of 120 cases].
Xu XH
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):321-5. PubMed ID: 3836822
[No Abstract] [Full Text] [Related]
34. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
[No Abstract] [Full Text] [Related]
35. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
Barkas T; Simpson JA
Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
[TBL] [Abstract][Full Text] [Related]
36. Effect of anti-acetylcholine receptor Fab fragments from goats on functional membrane-bound receptor.
Farach MC; Mihovilovic M; Paraschos A; Martinez-Carrion M
Arch Biochem Biophys; 1982 Mar; 214(1):140-54. PubMed ID: 7081993
[No Abstract] [Full Text] [Related]
37. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
[No Abstract] [Full Text] [Related]
38. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
Engel AG
J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
[TBL] [Abstract][Full Text] [Related]
39. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
[TBL] [Abstract][Full Text] [Related]
40. Immunopathology of myasthenia gravis.
Drachman DB
Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
